Type 1 diabetes mellitus and coronary revascularization
- 1 March 2019
- journal article
- review article
- Published by Wolters Kluwer Health in Cardiovascular Endocrinology & Metabolism
- Vol. 8 (1) , 35-38
Abstract
Over the last three decades, trials of coronary revascularization have taken into account whether populations did or did not have diabetes. What has not been considered is whether or not patients with diabetes in these studies have type 1 or type 2 diabetes. ‘Diabetes’ appears to be largely used as a synonym for type 2 diabetes. The number of patients with type 1 diabetes has not been reported in most trials. Many questions remain unanswered. Do patients with type 1 diabetes have the same response to various modes of revascularization as those with type 2 diabetes? We know type 2 diabetes affects coronary endothelial function and the coronary artery wall but to what extent does type 1 diabetes affect these? Any response to revascularization does not just depend on the coronary artery but also on the myocardium. How does type 1 diabetes affect the myocardium? To what extent do patients with type 1 diabetes have viable or ischaemic myocardium or scar? What does ‘diabetic cardiomyopathy’ refer to in the context of type 1 diabetes? This manuscript reviews the evidence for revascularization in type 1 diabetes. We conclude that there has been a near absence of investigation of the pros and cons of revascularization in this population. Investigations to establish both the nature and extent of coronary and myocardial disease in these populations are necessary. Clinical trials of the pros and cons of revascularization in type 1 diabetes are necessary; many will declare that these will be too challenging to perform.Keywords
This publication has 24 references indexed in Scilit:
- Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part IEuropean Heart Journal, 2013
- Strategies for Multivessel Revascularization in Patients with DiabetesNew England Journal of Medicine, 2012
- Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery DiseaseNew England Journal of Medicine, 2011
- Diabetic and Nondiabetic Patients With Left Main and/or 3-Vessel Coronary Artery DiseaseJACC, 2010
- Randomized Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Diabetic PatientsJACC, 2010
- Clinical and Angiographic Outcomes in Diabetics From the ENDEAVOR IV TrialJACC: Cardiovascular Interventions, 2009
- A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery DiseaseNew England Journal of Medicine, 2009
- Randomized, Controlled Trial of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery DiseaseCirculation, 2008
- Optimal Medical Therapy with or without PCI for Stable Coronary DiseaseNew England Journal of Medicine, 2007
- Coronary Intervention for Persistent Occlusion after Myocardial InfarctionNew England Journal of Medicine, 2006